Clinical Trial Update: Trial of THEO-260 in Ovarian Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update shows THEO-260 being studied for ovarian cancer and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• THEO-260

Snippet

Sponsor: Theolytics Limited | Conditions: Ovarian Cancer | Phase 1, Phase 2 | Status: RECRUITING